Cable Hill Partners, LLC Heron Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$16.93 - $26.22 $8,600 - $13,319	-508 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$23.15 - $28.34 $9,260 - $11,336	400 Added 370.37%	508 $12,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $6,570 - $8,946	-219 Reduced 66.97%	108 $3,000
Q2 2018 Aug 03, 2018	SELL	$26.4 - $42.0 $7,920 - $12,600	-300 Reduced 47.85%	327 $13,000
Q1 2018 Apr 20, 2018	BUY	$18.43 - $28.8 $2,340 - $3,657	127 Added 25.4%	627 $17,000
Q3 2017 Oct 27, 2017	BUY	$14.65 - $16.85 $7,325 - $8,425	500	500 $8,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.